Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo
Svetlana Paskaš(University of Belgrade), Danijela Maksimović‐Ivanić(Institute for Biological Research “Siniša Stanković”), Maria Sofia Basile(University of Catania), Emanuela Mazzon(Centro Neurolesi Bonino Pulejo), Sanja Mijatović(University of Belgrade), Sara Rakočević(University of Belgrade), Yousef Al‐Abed(Feinstein Institute for Medical Research), Mingzhu He(Feinstein Institute for Medical Research), Ferdinando Nicoletti(University of Catania), Eugenio Cavalli(Centro Neurolesi Bonino Pulejo)
Cited by 48
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495